Gut bacteria changes may foreshadow rheumatoid arthritis

Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.

Cancer Diagnoses Slow to Recover From Effects of COVID Pandemic

The decline in cancer diagnoses during the 2020 COVID pandemic did not translate into a spike in diagnoses in 2021, according to two separate studies.

September 26, 2024

Algernon Pharmaceuticals Engages Maxim Group to Explore Spin-Off of its Ifenprodil Phase 2 Chronic Cough Drug Development Program – Psychedelic Alpha

VANCOUVER, British Columbia, June 27, 2023 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage

June 27, 2023

FDA advisors unanimously reject Intarcia’s embattled type 2 diabetes treatment

I2o Therapeutics CEO Kurt Graves set out on Thursday to make a case to a panel of the FDA’s expert advisors that the benefits of

September 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.